GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zura Bio Ltd (STU:94E) » Definitions » Other Current Liabilities

Zura Bio (STU:94E) Other Current Liabilities : €0.66 Mil (As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Zura Bio Other Current Liabilities?

Zura Bio's other current liabilities for the quarter that ended in Mar. 2025 was €0.66 Mil.

Zura Bio's quarterly other current liabilities increased from Sep. 2024 (€1.23 Mil) to Dec. 2024 (€1.64 Mil) but then declined from Dec. 2024 (€1.64 Mil) to Mar. 2025 (€0.66 Mil).

Zura Bio's annual other current liabilities increased from Mar. 2022 (€0.00 Mil) to Dec. 2023 (€1.10 Mil) and increased from Dec. 2023 (€1.10 Mil) to Dec. 2024 (€1.64 Mil).


Zura Bio Other Current Liabilities Historical Data

The historical data trend for Zura Bio's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zura Bio Other Current Liabilities Chart

Zura Bio Annual Data
Trend Mar22 Dec23 Dec24
Other Current Liabilities
- 1.10 1.64

Zura Bio Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.36 1.42 1.23 1.64 0.66

Zura Bio Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


Zura Bio Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Zura Bio's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Zura Bio Business Description

Industry
Traded in Other Exchanges
Address
1489 W. Warm Springs Road, Suite 110, Henderson, NV, USA, 89014
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

Zura Bio Headlines

No Headlines